The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - PureCircle Limited

16 Apr 2020 14:35

RNS Number : 9271J
PureCircle Limited
16 April 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Alwaha Fund Ltd.

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PureCircle Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

Not applicable

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 April 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,201,706

3.36%

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

6,201,706

3.36%

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Not Applicable

Details, including nature of the rights concerned and relevant percentages:

Not Applicable

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

-

-

 

-

-

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

-

-

 

-

-

-

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

-

-

-

-

-

-

-

-

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

-

-

-

-

-

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

-

 

-

-

-

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

16 April 2020

Contact name:

Nik Hanim Nik Mahmood

Telephone number*:

+60129237921

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETFZGMDFVZGGZM
Date   Source Headline
14th Mar 20117:00 amRNSInterim Results and Investor Conference Call
13th Jan 20117:00 amRNSTrading Statement
15th Dec 201012:00 pmRNSAGM Statement
23rd Nov 20107:00 amRNSAGM Statement
9th Nov 20107:00 amRNSLong term incentive plan: Issue of shares
29th Oct 20107:00 amRNSDirector/PDMR Shareholding
28th Oct 20107:00 amRNSRe Audited accounts
23rd Sep 20108:08 amRNSRe Joint Venture
23rd Sep 20107:43 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSRe Joint Venture
22nd Sep 20107:00 amRNSFull Year Results
31st Aug 20107:00 amRNSNotice of Allowance for patent
3rd Aug 20107:00 amRNSStevia Trust Mark marketing campaign
29th Jul 20107:00 amRNSRe Global Quality Leaf Sourcing Strategy
28th Jul 20107:00 amRNSMajor contract wins
27th Jul 20107:00 amRNSInterim Management Statement
27th Jul 20107:00 amRNSProposed Joint Venture
26th Jul 20107:00 amRNSGlobal Sales and Marketing VP appointed
21st Jul 20107:00 amRNSFDA 'No Objection' ruling on new product
25th Jun 201012:02 pmRNSGlobal Stevia Institute announces key members
26th May 20107:00 amRNSLaunch of Global Stevia Institute
5th May 20107:00 amRNSNew products launching at a greater rate
14th Apr 20106:25 pmRNSEFSA evaluates the safety of steviol glycosides
6th Apr 20107:00 amRNSUpdate on New Product Launches
1st Apr 20109:59 amRNSChange of significant Shareholding
30th Mar 201011:18 amRNSIssue of new shares and exercise of options
22nd Mar 20107:00 amRNSHalf Yearly Report
5th Mar 20107:00 amRNSNotice of Results
4th Mar 20107:00 amRNSProduct Launches
26th Feb 20107:00 amRNSManagement changes
22nd Feb 20107:00 amRNSRe Joint Venture
9th Feb 20109:27 amRNSChange of Significant Shareholding
1st Feb 20107:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20107:00 amRNSProduct Launch
14th Jan 20109:09 amRNSRe Agreement
18th Dec 20097:00 amRNSSignificant shareholding
17th Dec 20097:00 amRNSSignificant Shareholders and Notifiable Interest
8th Dec 20099:11 amRNSissue of shares
24th Nov 200910:17 amRNSResult of AGM
23rd Nov 20097:00 amRNSNotifiable Interests
19th Nov 20097:00 amRNSissue of shares
18th Nov 20097:00 amRNSPlacing
16th Nov 20097:00 amRNSPureCircle collaboration with Nestle Malaysia
13th Nov 20097:00 amRNSPureCircle wins major award
11th Nov 20097:00 amRNSExpansion of supply source
6th Nov 20097:00 amRNSProduct Launch
4th Nov 20097:00 amRNSStevia product launches hit 200
2nd Nov 200911:15 amRNSAnnual Financial Report
30th Oct 20097:00 amRNSNotice of AGM
30th Oct 20097:00 amRNSStatement re Collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.